Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors

抗体双价通过独立于 Fc γ 受体抑制病毒释放来提高抗病毒疗效

阅读:17
作者:Mehmet Sahin, Melissa M Remy, Benedict Fallet, Rami Sommerstein, Marianna Florova, Anna Langner, Katja Klausz, Tobias Straub, Mario Kreutzfeldt, Ingrid Wagner, Cinzia T Schmidt, Pauline Malinge, Giovanni Magistrelli, Shozo Izui, Hanspeter Pircher, J Sjef Verbeek, Doron Merkler, Matthias Peipp, Danie

Abstract

Across the animal kingdom, multivalency discriminates antibodies from all other immunoglobulin superfamily members. The evolutionary forces conserving multivalency above other structural hallmarks of antibodies remain, however, incompletely defined. Here, we engineer monovalent either Fc-competent or -deficient antibody formats to investigate mechanisms of protection of neutralizing antibodies (nAbs) and non-neutralizing antibodies (nnAbs) in virus-infected mice. Antibody bivalency enables the tethering of virions to the infected cell surface, inhibits the release of virions in cell culture, and suppresses viral loads in vivo independently of Fc gamma receptor (FcγR) interactions. In return, monovalent antibody formats either do not inhibit virion release and fail to protect in vivo or their protective efficacy is largely FcγR dependent. Protection in mice correlates with virus-release-inhibiting activity of nAb and nnAb rather than with their neutralizing capacity. These observations provide mechanistic insights into the evolutionary conservation of antibody bivalency and help refining correlates of nnAb protection for vaccine development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。